Pharmacokinetics of oral tablet formulations
Pro Research Analysisby 
Searched over 200M research papers
Pharmacokinetics of Oral Tablet Formulations: Key Parameters and Bioequivalence
Absorption and Bioequivalence of Oral Tablets
Oral tablet formulations are widely used due to their convenience and patient compliance. Studies consistently show that the pharmacokinetics—how the body absorbs, distributes, metabolizes, and eliminates a drug—of oral tablets are often comparable to other oral dosage forms, such as capsules, solutions, and orally disintegrating tablets (ODTs), especially under fasting conditions. For example, morphine sulfate ODTs demonstrated similar time to maximum plasma concentration (Tmax), maximum plasma concentration (Cmax), and area under the curve (AUC) compared to immediate-release tablets and capsules, confirming their bioequivalence and suitability for patients with swallowing difficulties . Similarly, generic and branded cotrimoxazole tablets showed no significant differences in Cmax, AUC0-t, or AUC0-∞, with all pharmacokinetic parameters falling within the accepted bioequivalence range of 80–125% .
Comparison with Other Oral Formulations
Several studies have compared tablet formulations to oral solutions and suspensions. For citalopram, both the tablet and oral solution forms were rapidly absorbed, with similar pharmacokinetic profiles and no significant differences in half-life or oral clearance, confirming bioequivalence . For favipiravir, the oral solution and tablet formulations also met bioequivalence criteria, with similar Cmax and AUC values, and no adverse events reported . In the case of bempedoic acid, physiologically based pharmacokinetic (PBPK) modeling predicted that the rate and extent of absorption for oral suspension and immediate-release tablets would not differ meaningfully, supporting the interchangeability of these forms .
Orally Disintegrating and Gastroretentive Tablets
Orally disintegrating tablets (ODTs) are designed for patients who have trouble swallowing. Studies on ODTs, such as those for morphine sulfate and dexlansoprazole, show that these formulations provide plasma exposure and pharmacodynamic effects equivalent to traditional tablets or capsules, making them effective alternatives Atrux-Tallau2022Kambayashi2020Kukulka2016. For drugs like silymarin, gastroretentive floating matrix tablets have been developed to enhance oral bioavailability. These tablets prolong gastric residence time and provide sustained drug release, resulting in higher Cmax and AUC compared to conventional tablets .
Impact of Formulation and Modeling Approaches
The composition and design of tablet formulations can significantly affect drug release and pharmacokinetics. Advanced modeling approaches, such as in vitro–in vivo correlation (IVIVC) and PBPK models, are increasingly used to predict how changes in tablet composition impact pharmacokinetic parameters like Cmax and AUC. For example, an extended DoE-IVIVC model for donepezil sustained-release tablets accurately predicted pharmacokinetic outcomes based on formulation composition, supporting more efficient development of new tablet formulations . Similarly, PBPK models for bempedoic acid and simulation models for atorvastatin ODTs help anticipate in vivo performance and guide formulation optimization Amore2023Kambayashi2020.
Food Effects and Variability
Food can influence the absorption of oral tablets, but newer tablet and capsule formulations are often designed to minimize this effect. For instance, posaconazole tablets and capsules showed higher and less variable exposure than oral suspension, and their absorption was less affected by food intake . This consistency improves predictability and patient outcomes.
Conclusion
Oral tablet formulations generally provide reliable and predictable pharmacokinetics, with many studies confirming their bioequivalence to other oral forms such as solutions, suspensions, and ODTs. Advances in formulation science and modeling techniques further enhance the ability to predict and optimize the pharmacokinetic profiles of oral tablets, ensuring effective and safe drug delivery for a wide range of patients Atrux-Tallau2022Zuo2024Gutierrez2000+7 MORE.
Sources and full results
Most relevant research papers on this topic
Pharmacokinetic comparison of oral solution and tablet formulations of citalopram: a single-dose, randomized, crossover study.
Both oral solution and tablet formulations of citalopram 60 mg are bioequivalent in this population, with similar absorption rates and no significant differences in half-life or oral clearance.
A Physiologically-based Drug Absorption Modeling for Orally Disintegrating Tablets.
Orally disintegrating tablets can be simulated in fasted humans, with different gastric emptying parameters needed for each formulation to accurately describe plasma concentration profiles.
DOI